Evidence map›Paper›PMID 36562628›Full record

ArticleMolecular oncology2023

Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Valeria Vitelli, Thomas Fleischer, Jørgen Ankill, Elja Arjas, Arnoldo Frigessi, Vessela N Kristensen, Manuela Zucknick

Abstract read
In one paragraph

Article in Molecular oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Valeria VitelliOslo Centre for Biostatistics and Epidemiology, University of Oslo, Norway.ORCID 0000-0002-6746-0453
Thomas FleischerDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.ORCID 0000-0003-0985-8460
Jørgen AnkillDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.ORCID 0000-0002-5752-0299
Elja ArjasOslo Centre for Biostatistics and Epidemiology, University of Oslo, Norway.ORCID 0000-0001-6317-1761
Arnoldo FrigessiOslo Centre for Biostatistics and Epidemiology, University of Oslo, Norway.
Vessela N KristensenDepartment of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Norway.ORCID 0000-0001-5012-7438
Manuela ZucknickOslo Centre for Biostatistics and Epidemiology, University of Oslo, Norway.ORCID 0000-0003-1317-7422

Funding

Helse Sør-Øst RHF 2017065Helse Sør-Øst RHF 2020031Norges Forskningsråd 237718
6 · The paper itself

Abstract

The analysis of whole genomes of pan-cancer data sets provides a challenge for researchers, and we contribute to the literature concerning the identification of robust subgroups with clear biological interpretation. Specifically, we tackle this unsupervised problem via a novel rank-based Bayesian clustering method. The advantages of our method are the integration and quantification of all uncertainties related to both the input data and the model, the probabilistic interpretation of final results to allow straightforward assessment of the stability of clusters leading to reliable conclusions, and the transparent biological interpretation of the identified clusters since each cluster is characterized by its top-ranked genomic features. We applied our method to RNA-seq data from cancer samples from 12 tumor types from the Cancer Genome Atlas. We identified a robust clustering that mostly reflects tissue of origin but also includes pan-cancer clusters. Importantly, we identified three pan-squamous clusters composed of a mix of lung squamous cell carcinoma, head and neck squamous carcinoma, and bladder cancer, with different biological functions over-represented in the top genes that characterize the three clusters. We also found two novel subtypes of kidney cancer that show different prognosis, and we reproduced known subtypes of breast cancer. Taken together, our method allows the identification of robust and biologically meaningful clusters of pan-cancer samples.

Indexed as

Breast NeoplasmsCarcinoma, Squamous CellHead and Neck NeoplasmsBayes TheoremCluster AnalysisFemaleHumansTranscriptomeBayes Mallows modelcluster analysispan-cancerrobust statisticssubgroup analysistranscriptomics

Identifiers

PMID36562628
PMCPMC10061294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.